Almirall, S.A. (BME:ALM)
11.24
+0.08 (0.72%)
Jun 5, 2026, 5:35 PM CET
Almirall Market Cap
Almirall has a market cap or net worth of €2.41 billion as of June 5, 2026. Its market cap has increased by 2.81% in one year.
Market Cap
2.41B
Enterprise Value
2.39B
Revenue
1.12B
Ranking
n/a
PE Ratio
60.58
Stock Price
€11.24
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.41B, an increase of 1.80%. That is a compound annual growth rate of 0.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 2.41B | -12.46% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.55B |
| Laboratorios Farmaceuticos Rovi | 3.01B |
| Pharma Mar | 1.67B |
| Faes Farma | 1.42B |
| Clínica Baviera | 951.50M |
| Oryzon Genomics | 232.07M |
| Prim, S.A. | 225.43M |
| Laboratorio Reig Jofre | 220.63M |